Daxor Corporation Logo

Daxor Corporation

DXR

(3.2)
Stock Price

9,15 USD

17.11% ROA

18.6% ROE

7.59x PER

Market Cap.

45.574.279,00 USD

4.24% DER

0% Yield

16.77% NPM

Daxor Corporation Stock Analysis

Daxor Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Daxor Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (20.66%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (4%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

5 PBV

The stock's PBV ratio (1.06x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

9 Buffet Intrinsic Value

The company's stock seems undervalued (60) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Daxor Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Daxor Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Daxor Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Daxor Corporation Revenue
Year Revenue Growth
1985 1.800.000
1986 1.800.000 0%
1987 1.900.000 5.26%
1988 4.400.000 56.82%
1989 2.200.000 -100%
1990 4.600.000 52.17%
1991 3.900.000 -17.95%
1992 6.100.000 36.07%
1993 4.800.000 -27.08%
1994 4.600.000 -4.35%
1995 4.700.000 2.13%
1996 2.800.000 -67.86%
1997 500.000 -460%
1998 300.000 -66.67%
1999 575.376 47.86%
2000 745.788 22.85%
2001 758.368 1.66%
2002 2.701.937 71.93%
2003 3.165.437 14.64%
2004 1.218.406 -159.8%
2005 1.343.538 9.31%
2006 1.486.449 9.61%
2007 1.869.779 20.5%
2008 1.761.055 -6.17%
2009 1.688.826 -4.28%
2010 1.579.257 -6.94%
2011 1.277.422 -23.63%
2012 -2.102.214 160.77%
2013 -11.557.630 81.81%
2014 -4.053.710 -185.11%
2015 -7.443.855 45.54%
2016 1.835.331 505.59%
2017 -1.011.589 281.43%
2018 -918.449 -10.14%
2019 -114.992 -698.71%
2020 475.800 124.17%
2021 5.821.183 91.83%
2022 6.310.294 7.75%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Daxor Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 2.152.261 100%
2007 0 0%
2008 0 0%
2009 2.825.151 100%
2010 3.041.640 7.12%
2011 2.705.952 -12.41%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Daxor Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 -1.500.000
1986 -1.300.000 -15.38%
1987 -1.400.000 7.14%
1988 -1.000.000 -40%
1989 1.200.000 183.33%
1990 -500.000 340%
1991 4.300.000 111.63%
1992 1.100.000 -290.91%
1993 1.300.000 15.38%
1994 1.600.000 18.75%
1995 2.400.000 33.33%
1996 2.100.000 -14.29%
1997 -100.000 2200%
1998 -700.000 85.71%
1999 -309.710 -126.02%
2000 -470.587 34.19%
2001 -545.321 13.7%
2002 2.028.200 126.89%
2003 2.644.967 23.32%
2004 448.135 -490.22%
2005 1.024.999 56.28%
2006 1.231.897 16.8%
2007 -10.968.458 111.23%
2008 -18.884.892 41.92%
2009 -9.614.008 -96.43%
2010 -7.562.169 -27.13%
2011 12.952.626 158.38%
2012 353.737 -3561.65%
2013 365.729 3.28%
2014 398.018 8.11%
2015 378.090 -5.27%
2016 304.873 -24.02%
2017 124.596 -144.69%
2018 256.757 51.47%
2019 384.184 33.17%
2020 119.560 -221.33%
2021 991.309 87.94%
2022 1.085.486 8.68%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Daxor Corporation EBITDA
Year EBITDA Growth
1985 1.900.000
1986 1.800.000 -5.56%
1987 1.900.000 5.26%
1988 3.700.000 48.65%
1989 -1.000.000 470%
1990 3.300.000 130.3%
1991 -1.900.000 273.68%
1992 3.700.000 151.35%
1993 2.400.000 -54.17%
1994 2.100.000 -14.29%
1995 1.500.000 -40%
1996 100.000 -1400%
1997 -100.000 200%
1998 -300.000 66.67%
1999 -23.375 -1183.42%
2000 24.292 196.23%
2001 426.841 94.31%
2002 -117.052 464.66%
2003 -1.004.738 88.35%
2004 -507.726 -97.89%
2005 -1.223.168 58.49%
2006 -619.132 -97.56%
2007 12.188.169 105.08%
2008 19.969.981 38.97%
2009 7.608.878 -162.46%
2010 8.710.330 12.65%
2011 -11.868.001 173.39%
2012 -2.461.789 -382.09%
2013 -11.775.696 79.09%
2014 -4.271.761 -175.66%
2015 -7.720.029 44.67%
2016 1.504.705 613.06%
2017 -1.142.302 231.73%
2018 -1.097.072 -4.12%
2019 -495.697 -121.32%
2020 -27.571.840 98.2%
2021 4.748.197 680.68%
2022 5.250.587 9.57%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Daxor Corporation Gross Profit
Year Gross Profit Growth
1985 1.800.000
1986 1.800.000 0%
1987 1.900.000 5.26%
1988 4.400.000 56.82%
1989 2.200.000 -100%
1990 4.600.000 52.17%
1991 3.900.000 -17.95%
1992 6.100.000 36.07%
1993 4.800.000 -27.08%
1994 4.600.000 -4.35%
1995 4.700.000 2.13%
1996 2.800.000 -67.86%
1997 500.000 -460%
1998 300.000 -66.67%
1999 575.376 47.86%
2000 745.788 22.85%
2001 758.368 1.66%
2002 2.701.937 71.93%
2003 3.165.437 14.64%
2004 1.218.406 -159.8%
2005 21.974 -5444.76%
2006 920.707 97.61%
2007 1.393.968 33.95%
2008 1.245.001 -11.97%
2009 983.960 -26.53%
2010 851.607 -15.54%
2011 624.911 -36.28%
2012 -2.102.214 129.73%
2013 -11.557.630 81.81%
2014 -4.053.710 -185.11%
2015 -7.443.855 45.54%
2016 1.835.331 505.59%
2017 -1.011.589 281.43%
2018 -918.449 -10.14%
2019 -114.992 -698.71%
2020 -360.880 68.14%
2021 5.821.183 106.2%
2022 6.310.294 7.75%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Daxor Corporation Net Profit
Year Net Profit Growth
1985 1.800.000
1986 1.600.000 -12.5%
1987 900.000 -77.78%
1988 3.400.000 73.53%
1989 -500.000 780%
1990 2.900.000 117.24%
1991 -1.900.000 252.63%
1992 3.400.000 155.88%
1993 2.200.000 -54.55%
1994 1.800.000 -22.22%
1995 1.300.000 -38.46%
1996 -100.000 1400%
1997 -200.000 50%
1998 -400.000 50%
1999 -97.150 -311.73%
2000 -55.194 -76.02%
2001 299.355 118.44%
2002 -193.851 254.43%
2003 -1.076.189 81.99%
2004 -580.268 -85.46%
2005 -1.335.981 56.57%
2006 -785.531 -70.07%
2007 10.647.216 107.38%
2008 15.123.269 29.6%
2009 5.822.758 -159.73%
2010 4.968.264 -17.2%
2011 -7.185.639 169.14%
2012 1.186.968 705.38%
2013 -8.218.373 114.44%
2014 -976.703 -741.44%
2015 -9.146.350 89.32%
2016 1.455.763 728.29%
2017 -1.239.890 217.41%
2018 -885.775 -39.98%
2019 -495.697 -78.69%
2020 -14.193.200 96.51%
2021 4.748.197 398.92%
2022 5.178.133 8.3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Daxor Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 1 0%
1989 0 0%
1990 1 0%
1991 0 0%
1992 1 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 2 100%
2008 3 33.33%
2009 1 -200%
2010 1 0%
2011 -2 200%
2012 0 0%
2013 -2 100%
2014 0 0%
2015 -2 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 -4 100%
2021 1 400%
2022 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Daxor Corporation Free Cashflow
Year Free Cashflow Growth
1985 1.800.000
1986 1.600.000 -12.5%
1988 3.400.000 52.94%
1989 -500.000 780%
1990 2.300.000 121.74%
1991 1.200.000 -91.67%
1992 2.000.000 40%
1993 1.200.000 -66.67%
1994 900.000 -33.33%
1995 200.000 -350%
1996 100.000 -100%
1997 400.000 75%
1998 -900.000 144.44%
1999 -526.315 -71%
2000 -119.783 -339.39%
2001 210.634 156.87%
2002 -327.651 164.29%
2003 -1.158.949 71.73%
2004 -1.861.344 37.74%
2005 -1.441.356 -29.14%
2006 -3.784.796 61.92%
2007 -4.785.514 20.91%
2008 -4.705.735 -1.7%
2009 -7.419.847 36.58%
2010 -6.014.793 -23.36%
2011 -6.631.798 9.3%
2012 4.479.381 248.05%
2013 -9.042.663 149.54%
2014 -295.636 -2958.72%
2015 18.525.614 101.6%
2016 1.592.691 -1063.16%
2017 -1.172.515 235.84%
2018 -1.315.610 10.88%
2019 3.112.062 142.27%
2020 -1.336.910 332.78%
2021 -2.758.954 51.54%
2022 -769.298 -258.63%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Daxor Corporation Operating Cashflow
Year Operating Cashflow Growth
1985 1.800.000
1986 1.600.000 -12.5%
1988 3.400.000 52.94%
1989 -500.000 780%
1990 2.300.000 121.74%
1991 1.200.000 -91.67%
1992 2.300.000 47.83%
1993 1.300.000 -76.92%
1994 1.000.000 -30%
1995 300.000 -233.33%
1996 200.000 -50%
1997 400.000 50%
1998 -800.000 150%
1999 -471.201 -69.78%
2000 -106.494 -342.47%
2001 221.628 148.05%
2002 -212.772 204.16%
2003 -1.104.595 80.74%
2004 -1.830.381 39.65%
2005 -1.156.354 -58.29%
2006 -3.440.262 66.39%
2007 -3.143.025 -9.46%
2008 -4.039.425 22.19%
2009 -5.253.123 23.1%
2010 -5.690.083 7.68%
2011 -6.508.648 12.58%
2012 4.479.381 245.3%
2013 -9.042.663 149.54%
2014 -295.636 -2958.72%
2015 18.525.614 101.6%
2016 1.592.691 -1063.16%
2017 -1.172.515 235.84%
2018 -1.315.610 10.88%
2019 3.112.062 142.27%
2020 -1.336.910 332.78%
2021 -2.758.954 51.54%
2022 -769.298 -258.63%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Daxor Corporation Capital Expenditure
Year Capital Expenditure Growth
1985 0
1986 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 300.000 100%
1993 100.000 -200%
1994 100.000 0%
1995 100.000 0%
1996 100.000 0%
1997 0 0%
1998 100.000 100%
1999 55.114 -81.44%
2000 13.289 -314.73%
2001 10.994 -20.88%
2002 114.879 90.43%
2003 54.354 -111.35%
2004 30.963 -75.55%
2005 285.002 89.14%
2006 344.534 17.28%
2007 1.642.489 79.02%
2008 666.310 -146.51%
2009 2.166.724 69.25%
2010 324.710 -567.28%
2011 123.150 -163.67%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Daxor Corporation Equity
Year Equity Growth
1985 12.600.000
1986 14.100.000 10.64%
1987 15.300.000 7.84%
1988 18.700.000 18.18%
1989 18.200.000 -2.75%
1990 21.000.000 13.33%
1991 19.100.000 -9.95%
1992 22.300.000 14.35%
1993 24.400.000 8.61%
1994 29.200.000 16.44%
1995 32.100.000 9.03%
1996 31.800.000 -0.94%
1997 32.900.000 3.34%
1998 35.300.000 6.8%
1999 29.279.569 -20.56%
2000 38.671.838 24.29%
2001 35.328.967 -9.46%
2002 33.546.897 -5.31%
2003 36.417.170 7.88%
2004 39.881.319 8.69%
2005 38.744.801 -2.93%
2006 45.637.792 15.1%
2007 54.915.885 16.9%
2008 43.460.641 -26.36%
2009 47.625.337 8.74%
2010 46.995.044 -1.34%
2011 36.216.591 -29.76%
2012 35.113.819 -3.14%
2013 26.370.847 -33.15%
2014 24.580.735 -7.28%
2015 14.427.532 -70.37%
2016 15.344.309 5.97%
2017 13.757.621 -11.53%
2018 13.062.008 -5.33%
2019 12.765.669 -2.32%
2020 15.675.186 18.56%
2021 21.152.719 25.9%
2022 28.969.469 26.98%
2023 30.359.013 4.58%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Daxor Corporation Assets
Year Assets Growth
1985 17.500.000
1986 21.300.000 17.84%
1987 24.100.000 11.62%
1988 30.300.000 20.46%
1989 26.500.000 -14.34%
1990 32.100.000 17.45%
1991 29.200.000 -9.93%
1992 32.600.000 10.43%
1993 29.100.000 -12.03%
1994 35.000.000 16.86%
1995 37.700.000 7.16%
1996 37.300.000 -1.07%
1997 41.300.000 9.69%
1998 44.100.000 6.35%
1999 35.846.065 -23.03%
2000 49.575.118 27.69%
2001 43.540.153 -13.86%
2002 41.573.565 -4.73%
2003 48.300.532 13.93%
2004 55.929.480 13.64%
2005 59.565.053 6.1%
2006 78.166.312 23.8%
2007 102.560.500 23.79%
2008 76.824.181 -33.5%
2009 75.186.990 -2.18%
2010 91.195.415 17.55%
2011 85.724.861 -6.38%
2012 56.330.192 -52.18%
2013 47.394.235 -18.85%
2014 46.046.231 -2.93%
2015 20.893.308 -120.39%
2016 20.624.417 -1.3%
2017 19.311.178 -6.8%
2018 17.626.511 -9.56%
2019 14.201.069 -24.12%
2020 16.552.875 14.21%
2021 24.981.686 33.74%
2022 30.261.069 17.45%
2023 30.359.013 0.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Daxor Corporation Liabilities
Year Liabilities Growth
1985 4.600.000
1986 7.000.000 34.29%
1987 7.800.000 10.26%
1988 11.300.000 30.97%
1989 7.800.000 -44.87%
1990 11.100.000 29.73%
1991 10.100.000 -9.9%
1992 10.300.000 1.94%
1993 4.700.000 -119.15%
1994 3.900.000 -20.51%
1995 5.600.000 30.36%
1996 5.500.000 -1.82%
1997 8.400.000 34.52%
1998 8.800.000 4.55%
1999 6.566.496 -34.01%
2000 10.903.280 39.78%
2001 8.211.186 -32.79%
2002 8.026.668 -2.3%
2003 11.883.362 32.45%
2004 16.048.161 25.95%
2005 20.820.252 22.92%
2006 32.528.520 35.99%
2007 47.644.615 31.73%
2008 33.363.540 -42.8%
2009 27.561.653 -21.05%
2010 44.200.371 37.64%
2011 49.508.270 10.72%
2012 21.216.373 -133.35%
2013 21.023.388 -0.92%
2014 21.465.496 2.06%
2015 6.465.776 -231.99%
2016 5.280.108 -22.46%
2017 5.553.557 4.92%
2018 4.564.503 -21.67%
2019 1.435.400 -218%
2020 877.689 -63.54%
2021 3.828.967 77.08%
2022 1.291.600 -196.45%
2023 0 0%

Daxor Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.55
Net Income per Share
1.27
Price to Earning Ratio
7.59x
Price To Sales Ratio
7.22x
POCF Ratio
-51.09
PFCF Ratio
-59.24
Price to Book Ratio
1.36
EV to Sales
7.42
EV Over EBITDA
8.91
EV to Operating CashFlow
-60.84
EV to FreeCashFlow
-60.84
Earnings Yield
0.13
FreeCashFlow Yield
-0.02
Market Cap
0,05 Bil.
Enterprise Value
0,05 Bil.
Graham Number
14.23
Graham NetNet
-0.31

Income Statement Metrics

Net Income per Share
1.27
Income Quality
-0.15
ROE
0.21
Return On Assets
0.16
Return On Capital Employed
0.2
Net Income per EBT
1
EBT Per Ebit
0.83
Ebit per Revenue
0.2
Effective Tax Rate
-0.32

Margins

Sales, General, & Administrative to Revenue
0.17
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.97
Operating Profit Margin
0.2
Pretax Profit Margin
0.17
Net Profit Margin
0.17

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.19
Free CashFlow per Share
-0.19
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.17
Return on Tangible Assets
0.17
Days Sales Outstanding
1
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
366.18
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
7,09
Tangible Book Value per Share
7.09
Shareholders Equity per Share
7.09
Interest Debt per Share
0.32
Debt to Equity
0.04
Debt to Assets
0.04
Net Debt to EBITDA
0.23
Current Ratio
0
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.04
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Daxor Corporation Dividends
Year Dividends Growth
1997 1
1998 0 0%
2008 2 100%
2009 1 0%
2010 1 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%

Daxor Corporation Profile

About Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

CEO
Mr. Michael Richard Feldschuh
Employee
37
Address
109 Meco Lane
Oak Ridge, 37830

Daxor Corporation Executives & BODs

Daxor Corporation Executives & BODs
# Name Age
1 Mr. Robert J. Michel CPA, CPA, M.B.A.
Chief Financial Officer, Chief Compliance Officer & Corporate Secretary
70
2 Ms. Kathryn A. Kornafel
Senior Vice President of Marketing & Commercial Development
70
3 Mr. Michael Richard Feldschuh
Chairman, President & Chief Executive Officer
70
4 Ms. Linda Cooper
Vice President of Development & Operations
70
5 Mr. Guido Manzo
Vice President of Sales
70
6 Ms. Jean Oertel
Senior Vice President Commercialization & Customer Experience
70
7 Mr. Jonathan Adam Feldschuh
Chief Scientific Officer & Director
70

Daxor Corporation Competitors